Comprehensive Sterile Compounding (Aug 26 - 28, 2021)

Comprehensive Sterile Compounding is organized by American College of Apothecaries (ACA) and will be held from Aug 26 - 28, 2021 at American College of Apothecaries, Bartlett, Tennessee, United States of America.

Target Audience:
Physicians and other health care professionals are welcome to attend.

Accreditation:
Comprehensive Sterile Compounding, a practice-based course, has been approved for 20.0 contact hours (2 CEUs) of continuing education credit being obtained in the live programming with ACPE Universal Activity Numbers 0201-0000-20-001-L07 P/T. This UAN has an initial release date of 02/06/2020 and an expiration date of 02/06/2023. Attendees will be required to complete an evaluation form at the completion of the program. Attendees requesting CE will be required to provide their NABP e-Profile ID and birthdate (MMDD) to receive credit for any ACPE-accredited CPE session

Comprehensive Sterile Compounding: is an accredited 3-day, 20-hour (2.0 CEUs) practice-based course designed for pharmacists and technicians who are experienced in compounding.

Description:
Completion of the Fundamental Compounding Course is recommended. Physicians and other health care professionals are welcome to attend. This course will also provide initial aseptic training for pharmacists and technicians required by their state board of pharmacy in order to compound sterile preparations.
Participants are instructed in the proper aseptic techniques for preparations and quality control tests to prepare compounded sterile preparations.
Participants will work in a simulated sterile environment in a USP 795 laboratory, focusing on the aseptic process and practical knowledge that meet the requirements for USP 797.

During the third day, a non-sterile to sterile media-fill test process will be conducted in a USP 797 compliant clean room. Attendees will also learn how to prepare non-sterile to sterile compounds, including sterile solutions and manipulation of injectable solutions, cleaning and disinfection methods. Practical considerations about USP <800> will be discussed to facilitate the understanding of exposure routes and risks for those who handle hazardous drugs.

Learning Objectives:
At the conclusion of Comprehensive Sterile Compounding, the participating pharmacist or technician will be able to:
• Demonstrate aseptic technique by successfully performing gloved fingertip sampling and media-fill per USP 797 chapter
• Describe a quality assurance program including proficiency in core competencies, personnel validation, processes with evaluation, documentation, quality control and quality improvement
• Discuss Compounded Sterile Preparations Category 1 and Category 2, based on the conditions under which they are made, probability for microbial growth, and the time period within which they must be used, per USP 797
• Describe the various methods of sterilization, according to the USP 797, the process for validation and storage requirements
• Show how to write and implement a sterile compounding program compliant with USP 797
• Perform proper aseptic hand washing techniques and gowning procedures
• Prepare sterile preparations using different sterilization methods, including autoclave, dry heat sterilization, and sterilization by filtration
• Demonstrate how to maintain appropriate cleanliness conditions working in a horizontal and vertical laminar ?ow hoods
• Demonstrate filter membrane and validate filter integrity using bubble point testing
• Perform appropriate placement of materials and hands during compounding process, so that all critical sites receive first air in an ISO Class 5 environmen
• Describe compounded sterile preparations strength through Certificate of Analysis and other reference materials
• Discuss site-specific Standard Operating Procedures
• Prepare Category 1 and Category 2 preparations using aseptic techniques
• Prepare a non-sterile to sterile media-fill test, following the requirement in current USP <797> standard
• Discuss engineering controls according to USP <800>
• Identify hazardous drugs according to NIOSH (National Institute for Occupational Safety and Health)
• Discuss exposure routes and risks for those who handle hazardous drugs
• Describe good compounding process and practices, and personnel protective equipment (PPE) according to NIOSH guidelines to handle hazardous drugs and USP <800>